These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 32621749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apolipoprotein M Gene Polymorphism Rs805297 (C-1065A): Association With Type 2 Diabetes Mellitus and Related Microvascular Complications in South Egypt.
    Tageldeen MM, Badrawy H, Abdelmeguid M, Zaghlol M, Gaber N, Kenawy EM.
    Am J Med Sci; 2021 Jul; 362(1):48-55. PubMed ID: 33621527
    [Abstract] [Full Text] [Related]

  • 3. A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.
    Zhang PH, Gao JL, Pu C, Feng G, Wang LZ, Huang LZ, Zhang Y.
    Lipids Health Dis; 2016 Aug 30; 15(1):142. PubMed ID: 27576735
    [Abstract] [Full Text] [Related]

  • 4. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
    Ahmad A, Sundquist K, Zöller B, Dahlbäck B, Svensson PJ, Sundquist J, Memon AA.
    Thromb Haemost; 2016 Aug 30; 116(3):432-41. PubMed ID: 27277397
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.
    Liu M, Frej C, Langefeld CD, Divers J, Bowden DW, Carr JJ, Gebre AK, Xu J, Larsson B, Dahlbäck B, Freedman BI, Parks JS.
    J Lipid Res; 2019 Aug 30; 60(8):1425-1431. PubMed ID: 31133557
    [Abstract] [Full Text] [Related]

  • 9. Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese.
    Niu N, Zhu X, Liu Y, Du T, Wang X, Chen D, Sun B, Gu HF, Liu Y.
    Diabetes Metab Res Rev; 2007 Jan 30; 23(1):21-5. PubMed ID: 16572495
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apolipoprotein m (APOM) levels and APOM rs805297 G/T polymorphism are associated with increased risk of rheumatoid arthritis.
    Huang Y, Liu Y, Jiang L, Sun R, Zhang H, Liu R, Xu N.
    Joint Bone Spine; 2014 Jan 30; 81(1):32-6. PubMed ID: 23660425
    [Abstract] [Full Text] [Related]

  • 12. Interaction Between Apolipoprotein M Gene Single-Nucleotide Polymorphisms and Obesity and its Effect on Type 2 Diabetes Mellitus Susceptibility.
    Liu D, Pan JM, Pei X, Li JS.
    Sci Rep; 2020 May 12; 10(1):7859. PubMed ID: 32398715
    [Abstract] [Full Text] [Related]

  • 13. Effects of apolipoprotein M in uremic atherosclerosis.
    Bosteen MH, Madsen Svarrer EM, Bisgaard LS, Martinussen T, Madsen M, Nielsen LB, Christoffersen C, Pedersen TX.
    Atherosclerosis; 2017 Oct 12; 265():93-101. PubMed ID: 28866363
    [Abstract] [Full Text] [Related]

  • 14. Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and Mendelian randomization studies.
    Rolver MG, Emanuelsson F, Nordestgaard BG, Benn M.
    Cardiovasc Diabetol; 2024 May 10; 23(1):165. PubMed ID: 38730445
    [Abstract] [Full Text] [Related]

  • 15. Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate.
    Yafasova A, Mandrup CM, Egelund J, Nyberg M, Stallknecht B, Hellsten Y, Nielsen LB, Christoffersen C.
    J Appl Physiol (1985); 2019 Jan 01; 126(1):214-220. PubMed ID: 30433864
    [Abstract] [Full Text] [Related]

  • 16. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S, Shih DQ, Pearson ER, Wolfrum C, Fajans SS, Hattersley AT, Stoffel M.
    Diabetes; 2003 Dec 01; 52(12):2989-95. PubMed ID: 14633861
    [Abstract] [Full Text] [Related]

  • 17. Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies.
    Ahnström J, Axler O, Jauhiainen M, Salomaa V, Havulinna AS, Ehnholm C, Frikke-Schmidt R, Tybjaerg-Hansen A, Dahlbäck B.
    J Lipid Res; 2008 Sep 01; 49(9):1912-7. PubMed ID: 18490703
    [Abstract] [Full Text] [Related]

  • 18. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.
    Brøndum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG.
    Int J Epidemiol; 2015 Apr 01; 44(2):651-61. PubMed ID: 25981321
    [Abstract] [Full Text] [Related]

  • 19. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
    Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG.
    JAMA; 2009 Jun 10; 301(22):2331-9. PubMed ID: 19509380
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein M gene single nucleotide polymorphisms discovery in patients with chronic obstructive pulmonary disease and determined by the base-quenched probe technique.
    Yu Y, Zhang J, Qiao Y, Pan L, Li J, Mao H, Wei J, Zhang X, Xu N, Luo G.
    Gene; 2017 Dec 30; 637():9-13. PubMed ID: 28927745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.